Step by Step


Advance Practice Providers Grand Rounds - New Oral Anticoagulants: Uses and Pitfalls





Credit Hours: CME 1.00

Target Audience:

Advanced Practice Providers (APP) at UPMC and APP students and faculty precepting within UPMC

Educational Objectives:

Upon successful completion of this continuing pharmacy education program, the participant should be able to:

  • Identify the New Oral Anticoagulants (NOAC)
  • Compare the advantages and disadvantages of NOAC’s
  • Identify reversal strategies for NOAC’s

Suggested Additional Reading:

  1. Schulman S, et al. N Engl J Med 2009;361:2342-2352.
  2. Ansell JE, et al. N Engl J Med 2014;;369: 2093-2104.
  3. Connolly SJ, et al. N Engl J Med. 2009;361:1139-1151.
  4. Pollack CV Jr, et al. N Engl J Med. 2015;373:511-520.
  5. Siegal DM et al. N Engl J Med 2015;373:2413-2424.

Franklin A. Bontempo, MD — Associate Professor of Medicine, Division of Hematology/Oncology University of Pittsburgh
No relationships with industry relevant to the content of this educational activity have been disclosed.
Authors disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits. Each physician should only claim credit commensurate with the extent of their participation in the activity.

The University of Pittsburgh is an affirmative action, equal opportunity institution.